Literature DB >> 18381063

The orphan nuclear receptor DAX-1 acts as a novel transcriptional corepressor of PPARgamma.

Gwang Sik Kim1, Gha Young Lee, Balachandar Nedumaran, Yun-Yong Park, Kyung Tae Kim, Sang Chul Park, Young Chul Lee, Jae Bum Kim, Hueng-Sik Choi.   

Abstract

DAX-1 is an atypical nuclear receptor (NR) which functions primarily as a transcriptional corepressor of other NRs via heterodimerization. Peroxisome proliferator-activated receptor (PPAR) gamma is a ligand-dependent NR which performs a key function in adipogenesis. In this study, we evaluated a novel cross-talk mechanism between DAX-1 and PPARgamma. Transient transfection assays demonstrated that DAX-1 inhibits the transactivity of PPARgamma in a dose-dependent manner. DAX-1 directly competed with the PPARgamma coactivator (PGC)-1alpha for binding to PPARgamma. Endogenous levels of DAX-1 were significantly lower in differentiated 3T3-L1 adipocytes as compared to preadipocytes. Using a retroviral expression system, we demonstrated that DAX-1 overexpression downregulates the expression of PPARgamma target genes, resulting in an attenuation of adipogenesis in 3T3-L1 cells. Our results suggest that DAX-1 acts as a corepressor of PPARgamma and performs a potential function in the regulation of PPARgamma-mediated cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381063     DOI: 10.1016/j.bbrc.2008.03.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

Authors:  Rebecca B Riggins; Mary M Mazzotta; Omar Z Maniya; Robert Clarke
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

2.  The orphan nuclear receptor DAX-1 functions as a potent corepressor of the constitutive androstane receptor (NR1I3).

Authors:  Elizabeth M Laurenzana; Tao Chen; Malavika Kannuswamy; Brian E Sell; Stephen C Strom; Yong Li; Curtis J Omiecinski
Journal:  Mol Pharmacol       Date:  2012-08-15       Impact factor: 4.436

3.  Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.

Authors:  Arjen Koppen; Rene Houtman; Dirk Pijnenburg; Ellen H Jeninga; Rob Ruijtenbeek; Eric Kalkhoven
Journal:  Mol Cell Proteomics       Date:  2009-07-10       Impact factor: 5.911

4.  De novo synthesis of steroids and oxysterols in adipocytes.

Authors:  Jiehan Li; Edward Daly; Enrico Campioli; Martin Wabitsch; Vassilios Papadopoulos
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

5.  Orphan nuclear receptor DAX-1 acts as a novel corepressor of liver X receptor alpha and inhibits hepatic lipogenesis.

Authors:  Balachandar Nedumaran; Gwang Sik Kim; Sungpyo Hong; Young-Sil Yoon; Yong-Hoon Kim; Chul-Ho Lee; Young Chul Lee; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

Review 6.  PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Nucl Recept Signal       Date:  2010-04-16

7.  Phosphoenolpyruvate carboxykinase and glucose-6-phosphatase are required for steroidogenesis in testicular Leydig cells.

Authors:  Seung Won Ahn; Gil-Tae Gang; Surendar Tadi; Balachandar Nedumaran; Yong Deuk Kim; Ji Hoon Park; Gi Ryang Kweon; Seung-Hoi Koo; Keesook Lee; Ryun-Sup Ahn; Yong-Hyeon Yim; Chul-Ho Lee; Robert A Harris; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

8.  DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates gluconeogenic enzyme gene expression.

Authors:  Balachandar Nedumaran; Sungpyo Hong; Yuan-Bin Xie; Yong-Hoon Kim; Woo-Young Seo; Min-Woo Lee; Chul Ho Lee; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

9.  Molecular characterization of SMILE as a novel corepressor of nuclear receptors.

Authors:  Yuan-Bin Xie; Balachandar Nedumaran; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.